Citadel Advisors’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-151,350
| Closed | -$2.22M | – | 13017 |
|
|
2025
Q3 | $2.22M | Sell |
151,350
-3,685,542
| -96% | -$37.6M | ﹤0.01% | 5866 |
|
|
2025
Q2 | $37.7M | Sell |
3,836,892
-1,249,944
| -25% | -$10.3M | 0.01% | 1470 |
|
|
2025
Q1 | $37M | Buy |
5,086,836
+356,984
| +8% | +$3.12M | 0.01% | 1411 |
|
|
2024
Q4 | $37M | Buy |
4,729,852
+2,173,125
| +85% | +$17.9M | 0.01% | 1541 |
|
|
2024
Q3 | $18.9M | Buy |
2,556,727
+447,645
| +21% | +$3.76M | ﹤0.01% | 2107 |
|
|
2024
Q2 | $16.9M | Buy |
2,109,082
+539,540
| +34% | +$4.82M | ﹤0.01% | 2172 |
|
|
2024
Q1 | $18.3M | Sell |
1,569,542
-608,797
| -28% | -$6.74M | ﹤0.01% | 2167 |
|
|
2023
Q4 | $24.3M | Buy |
2,178,339
+674,330
| +45% | +$6.2M | ﹤0.01% | 1818 |
|
|
2023
Q3 | $23.2M | Buy |
1,504,009
+419,653
| +39% | +$7.04M | 0.01% | 1702 |
|
|
2023
Q2 | $20.5M | Sell |
1,084,356
-819,999
| -43% | -$14.4M | ﹤0.01% | 1848 |
|
|
2023
Q1 | $29M | Buy |
1,904,355
+954,043
| +100% | +$12.4M | 0.01% | 1561 |
|
|
2022
Q4 | $12.1M | Sell |
950,312
-184,110
| -16% | -$1.66M | ﹤0.01% | 2553 |
|
|
2022
Q3 | $6.57M | Buy |
1,134,422
+70,818
| +7% | +$311K | ﹤0.01% | 3422 |
|
|
2022
Q2 | $3.42M | Buy |
1,063,604
+650,485
| +157% | +$1.96M | ﹤0.01% | 4522 |
|
|
2022
Q1 | $1.56M | Buy |
413,119
+142,715
| +53% | +$919K | ﹤0.01% | 6643 |
|
|
2021
Q4 | $3.53M | Sell |
270,404
-19,450
| -7% | -$308K | ﹤0.01% | 5007 |
|
|
2021
Q3 | $5.68M | Sell |
289,854
-198,911
| -41% | -$3.63M | ﹤0.01% | 4067 |
|
|
2021
Q2 | $9.14M | Sell |
488,765
-19,102
| -4% | -$426K | ﹤0.01% | 3218 |
|
|
2021
Q1 | $12M | Buy |
507,867
+17,914
| +4% | +$413K | ﹤0.01% | 2708 |
|
|
2020
Q4 | $11.9M | Buy |
489,953
+480,519
| +5,093% | +$12.3M | ﹤0.01% | 2419 |
|
|
2020
Q3 | $242K | Buy |
+9,434
| New | +$299K | ﹤0.01% | 8497 |
|
Other funds holding ETNB
Citadel Advisors's ETNB Position: Q4 2025 in Review
Citadel Advisors sold out of 89bio (ETNB) in Q4 2025, closing a stake of 151,350 shares — an estimated $2.22M sold.
Citadel Advisors first reported a position in ETNB in Q3 2020 and held it in 21 quarters. The position peaked at $37.7M in Q2 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Citadel Advisors reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Citadel Advisors sold 151,350 89bio shares in Q4 2025, an estimated $2.22M.
- Citadel Advisors first reported a position in 89bio in Q3 2020 and held it in 21 quarters.
- Citadel Advisors's 89bio position peaked at $37.7M in Q2 2025.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.